Gemcitabine plus paclitaxel (GT) versus paclitaxel (T) as first-line treatment for anthracycline pre-treated metastatic breast cancer (MBC): Quality of life (QoL) and pain palliation results from the global phase III study

Gemcitabine plus paclitaxel (GT) versus paclitaxel (T) as first-line treatment for anthracycline pre-treated metastatic breast cancer (MBC): Quality of life (QoL) and pain palliation results from the global phase III study

Journal of Clinical Oncology ◽

10.1200/jco.2004.22.90140.621 ◽

2004 ◽

Vol 22 (14_suppl) ◽

pp. 621-621 ◽

Cited By ~ 9

Author(s):

C. Moinpour ◽

J. Wu ◽

G. Donaldson ◽

A. Liepa ◽

A. Melemed ◽

...

Keyword(s):

Breast Cancer ◽

Quality Of Life ◽

Metastatic Breast ◽

Phase Iii ◽

Line Treatment ◽

Pain Palliation ◽

First Line ◽

Phase Iii Study ◽

Phase III study of liposome-encapsulated doxorubicin (TLC D-99) and cyclophosphamide (CPA) vs. epirubicin (EPI) and CPA in first-line treatment of metastatic breast cancer (MBC)

European Journal of Cancer ◽

10.1016/s0959-8049(99)81679-7 ◽

1999 ◽

Vol 35 ◽

pp. S315 ◽

Cited By ~ 2

Author(s):

S. Chan ◽

N. Davidson ◽

E. Juozaityte ◽

F. Erdkamp ◽

L. Hooftman ◽

...

Keyword(s):

Breast Cancer ◽

Metastatic Breast ◽

Phase Iii ◽

Line Treatment ◽

First Line ◽

Phase Iii Study ◽

Prospective Multicenter Randomized Phase III Study of Weekly versus Standard Docetaxel (D2) for First-Line Treatment of Metastatic Breast Cancer

Oncology ◽

10.1159/000320640 ◽

2010 ◽

Vol 79 (3-4) ◽

pp. 197-203 ◽

Cited By ~ 11

Author(s):

Hans-Joachim Stemmler ◽

Nadia Harbeck ◽

Isolde Gröll de Rivera ◽

Ursula Vehling Kaiser ◽

Gerhard Rauthe ◽

...

Keyword(s):

Breast Cancer ◽

Metastatic Breast ◽

Phase Iii ◽

Line Treatment ◽

First Line ◽

Phase Iii Study ◽

Randomized phase III study of trastuzumab monotherapy followed by docetaxel and trastuzumab versus the combination of trastuzumab and docetaxel as first-line treatment in patients with HER2 positive metastatic breast cancer.

10.1158/0008-5472.sabcs-3132 ◽

2009 ◽

Cited By ~ 3

Author(s):

K Najagami ◽

K Inoue ◽

M Mizutani ◽

Y Hozumi ◽

Y Fujiwara ◽

...

Keyword(s):

Breast Cancer ◽

Metastatic Breast ◽

Phase Iii ◽

Line Treatment ◽

First Line ◽

Her2 Positive ◽

Phase Iii Study ◽

Trastuzumab Monotherapy ◽

Fulvestrant 500 Mg as First-Line Treatment in Hormone-Positive (HR+) Metastatic Breast Cancer (MBC) Patients (PTS): Prospective Evaluation of Activity, Safety, Quality of Life (QOL) and Tumour Markers Changes

Annals of Oncology ◽

10.1016/s0923-7534(20)32900-8 ◽

2012 ◽

Vol 23 ◽

pp. ix123

Author(s):

R. Palumbo ◽

G. Bernardo ◽

A. Riccardi ◽

F. Sottotetti ◽

B. Tagliaferri ◽

...

Keyword(s):

Breast Cancer ◽

Quality Of Life ◽

Metastatic Breast ◽

Tumour Markers ◽

Line Treatment ◽

Prospective Evaluation ◽

First Line ◽

Prospective Multicenter Randomized Phase III Study of Weekly versus Standard Docetaxel plus Doxorubicin (D4) for First-Line Treatment of Metastatic Breast Cancer

Oncology ◽

10.1159/000320625 ◽

2010 ◽

Vol 79 (3-4) ◽

pp. 204-210 ◽

Cited By ~ 7

Author(s):

Hans-Joachim Stemmler ◽

Nadia Harbeck ◽

Isolde Gröll de Rivera ◽

Ursula Vehling Kaiser ◽

Gerhard Rauthe ◽

...

Keyword(s):

Breast Cancer ◽

Metastatic Breast ◽

Phase Iii ◽

Line Treatment ◽

First Line ◽

Phase Iii Study ◽

Abstract P5-17-03: Quality of life (QoL) results from the TURANDOT trial comparing two bevacizumab (BEV)-containing regimens as first-line treatment for HER2-negative metastatic breast cancer (mBC)

10.1158/0008-5472.sabcs12-p5-17-03 ◽

2012 ◽

Cited By ~ 2

Author(s):

I Láng ◽

MJ Inbar ◽

Z Kahan ◽

R Greil ◽

S Beslija ◽

...

Keyword(s):

Breast Cancer ◽

Quality Of Life ◽

Metastatic Breast ◽

Line Treatment ◽

First Line ◽

Randomized phase III study of taxane versus TS-1 as first-line treatment for metastatic breast cancer (SELECT BC).

Journal of Clinical Oncology ◽

10.1200/jco.2014.32.15_suppl.1012 ◽

2014 ◽

Vol 32 (15_suppl) ◽

pp. 1012-1012 ◽

Cited By ~ 1

Author(s):

Fumikata Hara ◽

Nobuaki Matsubara ◽

Tsuyoshi Saito ◽

Toshimi Takano ◽

Youngjin Park ◽

...

Keyword(s):

Breast Cancer ◽

Metastatic Breast ◽

Phase Iii ◽

Line Treatment ◽

First Line ◽

Phase Iii Study ◽

Abstract P5-18-02: Nab-Paclitaxel-based therapy in the first line treatment of metastatic breast cancer (IBCSG 42-12/BIG 2-12 SNAP): Impact of different schedules on quality of life

10.1158/1538-7445.sabcs17-p5-18-02 ◽

2018 ◽

Author(s):

K Ribi ◽

Z Sun ◽

G Jerusalem ◽

U Hasler-Strub ◽

M Colleoni ◽

...

Keyword(s):

Breast Cancer ◽

Quality Of Life ◽

Metastatic Breast ◽

Line Treatment ◽

First Line ◽

Quality-of-life and quality-adjusted survival (Q-TWiST) in patients receiving lapatinib in combination with paclitaxel as first-line treatment for metastatic breast cancer

Current Medical Research and Opinion ◽

10.1185/03007991003590860 ◽

2010 ◽

Vol 26 (4) ◽

pp. 767-775 ◽

Cited By ~ 11

Author(s):

Beth Sherrill ◽

Angelo Di Leo ◽

Mayur M. Amonkar ◽

Yun Wu ◽

Zanete Zvirbule ◽

...

Keyword(s):

Breast Cancer ◽

Quality Of Life ◽

Metastatic Breast ◽

Line Treatment ◽

First Line ◽